drugset / Trial / NCT03709355
Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs
RandomizedFactorialOpen-labelTreatment
Summary
The study assesses PK and safety of other drugs, such as some antibiotics, proton pump inhibitors, statins, and combined oral contraceptives when co-administered with Elpida®
Timeline
- Start
- 2018-11-14
- Primary completion
- 2019-09-06
- Completion
- 2019-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | — |
| Subject | Clarithromycin | Small molecule | 250 mg | — |
| Subject | Elsulfavirine | Small molecule | 20 mg | — |
| Subject | Levonorgestrel | Small molecule | 150 ug | — |
| Subject | Omeprazole | Other / unclassified | 20 mg | — |
| Subject | Rifabutin | Small molecule | 150 mg | — |
| Subject | Rifampicin | Small molecule | 150 mg | — |
| Subject | ethinyl estradiol | Small molecule | 30 ug | — |